Carotid Plaque Macrophages: A New Cellular Map for Predicting Heart Attacks
A landmark study using single-cell RNA sequencing on carotid artery plaques has identified four distinct archetypes of macrophages, key immune cells in atherosclerosis. Researchers found that these cells, particularly lipid-associated macrophages (LAMs) and inflammatory LAMs, originate from circulating monocytes. Crucially, the study established a direct clinical link: a higher burden of these specific macrophage subtypes, marked by genes like PLIN2 and TREM1, is significantly associated with an increased risk of major adverse cardiovascular events, such as heart attack or stroke, within three years after a patient undergoes carotid endarterectomy.
Why it might matter to you: This research moves atherosclerosis from a static pathological description to a dynamic model with predictive cellular biomarkers. For pharmacology, it identifies novel, high-specificity targets like TREM1 within defined inflammatory macrophage populations for next-generation drug development. It also provides a potential framework for therapeutic drug monitoring of anti-inflammatory therapies, allowing clinicians to assess treatment efficacy by measuring changes in these specific plaque cell signatures.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
